Endothelial progenitor cells in systemic lupus erythematosus

Area of Science:

• Immunology
• Cardiovascular Research
• Rheumatology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease with a significantly increased risk of atherosclerosis.
• Endothelial progenitor cells (EPCs) are crucial for repairing damaged blood vessels.
• Understanding EPC function in SLE is vital for assessing cardiovascular risk.

Purpose of the Study:

• To investigate EPC regeneration and mobilization in SLE patients.
• To correlate EPC function with disease activity and treatment regimens.
• To explore the impact of SLE on microvascular repair mechanisms.

Main Methods:

• Analysis of 48 SLE patients and age/sex-matched healthy controls.
• Flow cytometry (FACS) for enumerating circulating EPCs.
• Colony-forming assays for regenerative capacity and ELISA for vasomodulatory mediators.

Main Results:

• SLE patients showed normal circulating EPC percentages but significantly reduced regenerative capacity.
• Impaired EPC regeneration correlated with low/high disease activity, hypertension, and renal involvement.
• Patients on glucocorticoids or not on hydroxychloroquine (HCQ) exhibited defective EPC regeneration.

Conclusions:

• SLE is characterized by defective EPC regeneration and mobilization, impairing vascular repair.
• This EPC dysfunction may exacerbate microvascular damage in SLE.
• Long-term glucocorticoid therapy might suppress EPCs, while HCQ could impede their regeneration.